Skip to main content
SpringerLink
Log in

Cabergoline: a long-acting alternative to bromocriptine

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rains CP, Bryson HM, Fitton A. Cabergoline: a review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 1995 Feb; 49(2): 255–79

    Article  PubMed  CAS  Google Scholar 

  2. Ho KY, Thorner MO. Therapeutic applications of bromocriptine in endocrine and neurological diseases. Drugs 1988; 36: 67–82

    Article  PubMed  CAS  Google Scholar 

  3. Serri O. Progress in the management of hyperprolactinamia [editorial]. New Eng J Med 1994 Oct 6; 331(14): 942–4

    Article  PubMed  CAS  Google Scholar 

  4. Sandoz withdrawing Parlodel postpartum lactation suppression indication. FDC Report — Pink Sheet 1994 Aug 22; T&G 1

  5. Parlodel indication withdrawn in Italy. Scrip 1995 May 5; (2022): 23

  6. British National Formulary No. 29. London: The Pharmaceutical Press, 1995; 307–8

  7. New Ethicals Compendium. 5th Ed. Auckland: Adis International Ltd, 1994; 551–3

  8. Clinical Pharmacokinetics: drug data handbook 1990. Auckland: Adis Press Ltd, 1990; 21

  9. Webster J, Piscitelli G, Polli A, et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 1994 Oct 6; 331(14): 904–9

    Article  PubMed  CAS  Google Scholar 

  10. Giusti M, Porcella A, Carraro M, et al. A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients. J Endocrinol Invest 1994; 17: 51–7

    PubMed  CAS  Google Scholar 

  11. European Multicentre Study Group for Cabergoline in Lactation Inhibition. Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind multicentre study. BMJ 1991 Jun 8; 302: 1367–71

    Article  Google Scholar 

  12. Giorda G, Devincentiis S, Motta T, et al. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery. Gynecol Obstet Invest 1991; 31(2): 93–6

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cabergoline: a long-acting alternative to bromocriptine. Drugs Ther. Perspect 6, 1–5 (1995). https://doi.org/10.2165/00042310-199506050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199506050-00001

Keywords

Search

Navigation